Company Search:
Advanced Search
Sponsored Links
La Jolla Pharmaceutical Company Company Snapshot
La Jolla Pharmaceutical Company operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares La Jolla Pharmaceutical Company with three other companies in this sector in the United States: Curis, Inc. (2018 sales of $10.43 million of which 100% was Therapeutic Drug Dev), Titan Pharmaceuticals Inc ($6.62 million of which 100% was Development of Pharmaceutical Products), and Enzon Pharmaceuticals, Inc. ($6.92 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
La Jolla Pharmaceutical Company
  Stock Performance Chart for La Jolla Pharmaceutical Company
  Stock Data: Recent Stock Performance:
  Current Price (1/17/2020): 7.73
(Figures in U.S. Dollars)
1 Week 28.8%   13 Weeks 96.7%  
4 Weeks -8.5%   52 Weeks 22.7%  
La Jolla Pharmaceutical Company Key Data:
  Ticker: LJPC Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 10,056,000
(Year Ending Jan 2019).
Employees: 169
  Currency: U.S. Dollars Market Cap: 209,849,302
  Fiscal Yr Ends: December Shares Outstanding: 27,147,387
  Share Type: Common Closely Held Shares: 1,647,804
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.